Clinical Trial Update: Safety Assessment of Femoropopliteal Endovascular Treatment With PAclitaxel-coated Devices (SAFE-PAD Study)

View source ↗

Summary

The SAFE-PAD study completed its safety assessment of paclitaxel-coated devices used in femoropopliteal endovascular treatment for peripheral arterial disease, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Arterial Disease

Drugs mentioned

• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: Peripheral Arterial Disease, Paclitaxel Adverse Reaction | Status: COMPLETED